1.
Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines. Bangladesh J Pharmacol [Internet]. 2015 Dec. 25 [cited 2026 Jul. 1];11(1):130-7. Available from: https://banglajol.info/index.php/BJP/article/view/24149